PRINTER'S NO. 3435
No. 443 Session of 1998
INTRODUCED BY KENNEY, ORIE, MICOZZIE, L. I. COHEN, ROSS,
ZIMMERMAN, BELARDI, GEIST, FEESE, MAHER, HERSHEY, NAILOR,
READSHAW, M. COHEN, DRUCE, PETRONE, BAKER, GEORGE,
CALTAGIRONE, COY, RUBLEY, DeWEESE, PESCI, WOJNAROSKI, BROWNE,
DALEY, STERN, ROBINSON, BEBKO-JONES, SANTONI, FICHTER,
DeLUCA, GODSHALL, BARRAR, MANDERINO, TRELLO, HARHAI, HESS,
DALLY, LAUGHLIN, BARD, ZUG, JAMES, WALKO, SEYFERT, RAMOS,
SATHER, ROBERTS, B. SMITH, E. Z. TAYLOR, OLASZ, ROONEY,
YOUNGBLOOD, BOSCOLA, HORSEY, GIGLIOTTI, STABACK, MILLER,
SHANER, CAPPABIANCA, SAINATO, ITKIN, KIRKLAND, McGEEHAN,
C. WILLIAMS, HALUSKA, LUCYK, ADOLPH, McNAUGHTON, HENNESSEY,
DONATUCCI AND PIPPY, APRIL 22, 1998
REFERRED TO COMMITTEE ON INTERGOVERNMENTAL AFFAIRS,
APRIL 22, 1998
A RESOLUTION
1 Memorializing the President of the United States and the
2 Congress of the United States to enact H.R. 953, the Ovarian
3 Cancer Research and Information Amendments of 1997, to
4 authorize $90 million to conduct ovarian cancer research.
5 WHEREAS, It is estimated that 26,800 new cases of ovarian
6 cancer developed in the United States in 1997; and
7 WHEREAS, Ovarian cancer caused approximately 14,200 deaths in
8 1997; and
9 WHEREAS, Ovarian cancer ranks second among gynecological
10 cancers in the number of new cases each year and causes more
11 deaths than any other cancer of the female reproductive system;
12 and
13 WHEREAS, Approximately 78% of ovarian cancer patients survive
1 longer than one year after diagnosis and more than 46% of these
2 patients survive longer than five years after diagnosis; and
3 WHEREAS, If diagnosed and treated before the cancer spreads
4 outside of the ovary, the five-year survival rate is 92%, but
5 approximately only 24% of all cases of ovarian cancer is
6 detected at this stage; and
7 WHEREAS, Ovarian cancer research is desperately needed to
8 serve as encouragement to more women to undergo screening tests
9 earlier as well as to reduce the medical costs associated with
10 later discovery; and
11 WHEREAS, H.R. 953 in the House of Representatives of the
12 United States, to be known as the Ovarian Cancer Research and
13 Information Amendments of 1997, would authorize $90 million to
14 conduct ovarian cancer research; therefore be it
15 RESOLVED, That the House of Representatives of the
16 Commonwealth of Pennsylvania memorialize the President of the
17 United States and the Congress of the United States to enact
18 H.R. 953, the Ovarian Cancer Research and Information Amendments
19 of 1997; and be it further
20 RESOLVED, That a copy of this resolution be transmitted to
21 the President of the United States, to the presiding officers of
22 each house of Congress and to each member of Congress from
23 Pennsylvania.
D1L82DMS/19980H0443R3435 - 2 -